“…We identified : one trial each for aripiprazole (Keck et al 2007), olanzapine+mood stabilizer , oxcarbazepine+lithium (Vieta et al 2008a), perphenazine+mood stabilizer (Zarate & Tohen, 2004), risperidone long-acting injectable monotherapy (Quiroz et al 2010), risperidone long-acting injectable+mood stabilizer (Macfadden et al 2009) and ziprasidone+mood stabilizer ; two trials for carbamazepine (Greil et al 1997 ;Hartong et al 2003) and quetiapine+mood stabilizer (Suppes et al 2009 ;Vieta et al 2008 b) and quetiapine monotherapy Young et al 2008) ; three trials each for divalproex (Bowden et al 2000a, b ;Greil et al 1997 ;Tohen et al 2003), lamotrigine Calabrese et al 2000Calabrese et al , 2003 and olanzapine (Tohen et al 2003(Tohen et al , 2005(Tohen et al , 2006 ; and eight trials for lithium (Bowden et al 2000(Bowden et al b, 2003Calabrese et al 2003Calabrese et al , 2005Greil et al 1997 ;Hartong et al 2003 ;Tohen et al 2005 ;Vieta et al 2008a). BPRS, Brief Psychiatric Rating Scale ; CGI-S, Clinical Global Impression -Severity ; CGI-C, Clinical Global Impression -Change ; CI, confidence interval ; GAF, global assessment of functioning ; HAMD, Hamilton Rating Scale for Depression ; IR, insufficient response ; MADRS, Montgomery-Å sberg Depression Rating Scale ; MRS, Mania Rating Scale ; TEM, treatment-emergent mania ; YMRS, Young Mania Rating Scale.…”